<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02498106</url>
  </required_header>
  <id_info>
    <org_study_id>P14.332</org_study_id>
    <secondary_id>836031016</secondary_id>
    <secondary_id>NL51850.058.14</secondary_id>
    <secondary_id>5176</secondary_id>
    <nct_id>NCT02498106</nct_id>
  </id_info>
  <brief_title>Diet and Aggression: Reducing Aggression Among Chronic Psychiatric Inpatients Through Dietary Supplementation</brief_title>
  <official_title>Diet and Aggression: Reducing Aggression Among Chronic Psychiatric Inpatients Through Supplementation of Multivitamins, Minerals and n-3 Fatty Acids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Atrium Innovations</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal of this study is to investigate whether the daily administration of
      multivitamins, minerals and n-3 fatty acids will reduce aggression in long-term psychiatric
      inpatients and will thereby reduce costs of care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aggressive incidents are highly prevalent among chronic psychiatric inpatients. Previous
      studies have demonstrated the potential of multivitamin-, mineral-, and n-3 fatty acids
      (n-3FA) supplementation to reduce aggression in adolescent and forensic populations. To test
      the hypothesis that multivitamin-, mineral-, and n-3FA supplementation reduces aggression
      among chronic psychiatric inpatients, we designed a pragmatic, randomised, double-blind,
      placebo controlled, multicentre intervention study among psychiatric inpatients residing in
      long-stay psychiatric wards. During 6 months, one group receives 2 supplements daily from
      Orthica: one containing vitamins and minerals (vitamins [B1, B2, B3, B5, B6, B11, B12, C, D,
      E, Beta Carotene; Calcium, Iodine, Copper, Magnesium, Selenium, Iron, Zinc, Potassium,
      Chrome, Manganese]) and one containing fish fatty acids (n-3FA: eicosapentaenic acid [EPA]
      and docosahexaenic acid [DHA]) and the other group receives 2 placebo capsules.

      The main study parameter is the number of aggressive incidents from baseline (t0) to endpoint
      (six months post baseline, t3). Patients who wish to participate enter a 2-week run-in phase
      in which they take 2 placebo capsules daily. After positive evaluation of this run-in phase
      patients are randomized to the active or the control condition. Participants will then start
      the daily use of 2 supplement capsules or 2 placebo capsules, which will continue for 6
      months. At 3 time points (at baseline [t0] and at 2 and 6 months post-baseline [t2 and t3]),
      three questionnaires measuring feelings of aggression, quality of life, and psychiatric
      symptoms will be administered. Also, at t0 and t3 (micro)nutrient status will be determined.
      Finally, at 4 time points (t0, 2 weeks post baseline [t1], t2 and t3), nursing staff will
      report on observed levels of aggression and social dysfunction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of aggressive incidents</measure>
    <time_frame>daily for the total duration of the (six-month) intervention period</time_frame>
    <description>The main study parameter is the number of aggressive incidents from baseline (t0) to endpoint (six months post baseline, t3), as registered daily on the ward by nurses using the Dutch version of the Staff Observation Aggression Scale- Revised version (SOAS-R)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient feelings of aggression</measure>
    <time_frame>At 3 points (baseline [t0], 2 months post baseline [t2] and six months post baseline[ t3])</time_frame>
    <description>the Aangepaste Versie van de Agressievragenlijst (AVL-AV, 1), a 12 item self-report questionnaire about feelings of aggression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient quality of life</measure>
    <time_frame>At 3 points (baseline [t0], 2 months post baseline [t2] and six months post baseline[ t3])</time_frame>
    <description>the World Health Organization Quality of Life Questionnaire (WHO-QL-bref 5), a 26-item observer rated quality of life instrument.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient psychiatric symptoms</measure>
    <time_frame>At 3 points (baseline [t0], 2 months post baseline [t2] and six months post baseline[ t3])</time_frame>
    <description>The verkorte Comprehensive Psychopathological Rating Scale (vCPRS), a 25-item observer rated instrument on affective symptoms, which includes the Montgomery-Ã…sberg Depression Rating Scale (MADRS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observed patient social dysfunction</measure>
    <time_frame>At 4 points (baseline [t0], 2 weeks post baseline [t1], 2 months post baseline[t2] and six months post baseline [t3])</time_frame>
    <description>Nursing staff will fill in the Social Dysfunction Aggression Scale (SDAS), measuring observed levels of aggression and social dysfunction.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient micronutrient status</measure>
    <time_frame>At 2 points (baseline [t0] and six months post baseline [t3])</time_frame>
    <description>Blood samples (50cc) will be taken to determine micronutrient status, including Vitamins A, E, B1, B6, B12, D, and folate, total iron, magnesium, and the fatty acid spectrum.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Psychiatric Hospitalization</condition>
  <arm_group>
    <arm_group_label>nutritional supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intervention:2 Orthica Soft Multi Mini capsules and 1 Orthica Fish EPA Mini capsule per day; duration: 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>During 6 months one group receives 3 placebo supplements daily with identical look and feel to Orthica Soft Multi Mini and Orthica Fish EPA Mini</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Orthica Soft Multi Mini and Orthica Fish EPA Mini</intervention_name>
    <description>daily intake of 2 Orthica Soft Multi Mini capsules (containing vitamins [B1, B2, B3, B5, B6, B11, B12, C, D, E, Beta Carotene] and minerals [Iodine, Copper, Selenium, Iron, Zinc, Chrome, Manganese]) and 1 Orthica Fish EPA Mini capsule (containing n-3FA: eicosapentaenic acid [EPA] and docosahexaenic acid [DHA])</description>
    <arm_group_label>nutritional supplement</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  residing at a facility for long-term psychiatric inpatient care

          -  age 18 or over

        Exclusion Criteria:

          -  pregnancy

          -  breastfeeding

          -  known contra-indication for using the supplements used in this study

          -  expected discharge or transfer within the next 8 weeks

          -  current use of dietary supplements and refusal to stop using these for the duration of
             the study

          -  failure to complete run-in phase

          -  contra-indication for the use of pork-gelatin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erik J. Giltay, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Leiden University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nienke J. de Bles, MSc</last_name>
    <phone>(+31) 71 5261175</phone>
    <email>n.j.de_bles@lumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nathaly Rius Ottenheim, MD PhD</last_name>
    <phone>(+31) 71 5263448</phone>
    <email>n.rius_ottenheim@lumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rivierduinen High Care Psychiatric Clinic</name>
      <address>
        <city>Oegstgeest</city>
        <zip>2342 EB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan P.A. M. Bogers, MD</last_name>
      <phone>(+31)071 890 71 30</phone>
      <email>j.bogers@ggzleiden.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Parnassia wonen met zorg</name>
      <address>
        <city>The Hague</city>
        <zip>2512 HN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Constant Mouton, MD</last_name>
      <phone>(+31) 088-357 55 75</phone>
      <email>C.Mouton@parnassiagroep.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Hornsveld RH, Muris P, Kraaimaat FW, Meesters C. Psychometric properties of the aggression questionnaire in Dutch violent forensic psychiatric patients and secondary vocational students. Assessment. 2009 Jun;16(2):181-92. doi: 10.1177/1073191108325894. Epub 2008 Oct 13.</citation>
    <PMID>18852480</PMID>
  </reference>
  <reference>
    <citation>Nijman H, Palmstierna T. Measuring aggression with the staff observation aggression scale--revised. Acta Psychiatr Scand Suppl. 2002;(412):101-2.</citation>
    <PMID>12072137</PMID>
  </reference>
  <reference>
    <citation>Asberg M, Schalling D. Construction of a new psychiatric rating instrument, the Comprehensive Psychopathological Rating Scale (CPRS). Prog Neuropsychopharmacol. 1979;3(4):405-12.</citation>
    <PMID>400996</PMID>
  </reference>
  <reference>
    <citation>Skevington SM, Lotfy M, O'Connell KA; WHOQOL Group. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004 Mar;13(2):299-310.</citation>
    <PMID>15085902</PMID>
  </reference>
  <reference>
    <citation>Schoenthaler SJ, Bier ID. The effect of vitamin-mineral supplementation on juvenile delinquency among American schoolchildren: a randomized, double-blind placebo-controlled trial. J Altern Complement Med. 2000 Feb;6(1):7-17.</citation>
    <PMID>10706231</PMID>
  </reference>
  <reference>
    <citation>Gesch CB, Hammond SM, Hampson SE, Eves A, Crowder MJ. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. Br J Psychiatry. 2002 Jul;181:22-8.</citation>
    <PMID>12091259</PMID>
  </reference>
  <reference>
    <citation>Zaalberg A, Nijman H, Bulten E, Stroosma L, van der Staak C. Effects of nutritional supplements on aggression, rule-breaking, and psychopathology among young adult prisoners. Aggress Behav. 2010 Mar-Apr;36(2):117-26. doi: 10.1002/ab.20335.</citation>
    <PMID>20014286</PMID>
  </reference>
  <reference>
    <citation>LÃ©garÃ© N, Brosseau E, Joyal CC. Omega-3 and violence in schizophrenia. Schizophr Res. 2007 Nov;96(1-3):269. Epub 2007 Jul 16.</citation>
    <PMID>17629678</PMID>
  </reference>
  <reference>
    <citation>Benton D. The impact of diet on anti-social, violent and criminal behaviour. Neurosci Biobehav Rev. 2007;31(5):752-74. Epub 2007 Mar 4. Review.</citation>
    <PMID>17433442</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2015</study_first_submitted>
  <study_first_submitted_qc>July 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2015</study_first_posted>
  <last_update_submitted>July 25, 2017</last_update_submitted>
  <last_update_submitted_qc>July 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Leiden University Medical Center</investigator_affiliation>
    <investigator_full_name>Erik J. Giltay, MD, PhD</investigator_full_name>
    <investigator_title>Erik J. Giltay, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>nutrition</keyword>
  <keyword>aggression</keyword>
  <keyword>n-3 fatty acids</keyword>
  <keyword>psychiatry</keyword>
  <keyword>inpatients admitted &gt;2 years</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aggression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

